Abstract | AIM: MATERIAL AND METHODS: A total of 500 outpatients with primary AH and risk factors including the risk of stroke received Hyzaar ( losartan 50/100 mg and hydrochlorthiaside 12.5/25 mg) for one year. RESULTS: More frequent RF in hypertensive patients are the following: high blood cholesterol (86.7%), left ventricular hypertrophy (53.2%), familial history of AH (74.2%). A combination of three and two RF occurs in 49.1 and 37% hypertensive patients, respectively. A 6-month treatment with Hyzaar lowered systolic blood pressure by 28.4 mm Hg and diastolic one by 15.4 mm Hg. The target blood pressure was achieved in 83.5%. Real clinical practice showed that administration of a target Hyzaar dose for 6 months leads to a 6.5% regress of left ventricular hypertrophy, an 11% decrease of total cholesterol, a 4% decrease of glucose and a 8.9% decrease of uric acid. CONCLUSION: A control of AH and correction of RF in hypertensive patients with a high RF of stroke and other cardiovascular complications is real in use of adequate antihypertensive therapy.
|
Authors | M G Bubnova, R G Oganov |
Journal | Terapevticheskii arkhiv
(Ter Arkh)
Vol. 81
Issue 9
Pg. 19-23
( 2009)
ISSN: 0040-3660 [Print] Russia (Federation) |
PMID | 19827647
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Drug Combinations
- hydrochlorothiazide, losartan drug combination
- Hydrochlorothiazide
- Losartan
|
Topics |
- Aged
- Drug Combinations
- Female
- Humans
- Hydrochlorothiazide
(administration & dosage, therapeutic use)
- Hypertension
(blood, complications, drug therapy)
- Losartan
(administration & dosage, therapeutic use)
- Male
- Middle Aged
- Risk Factors
- Stroke
(etiology, prevention & control)
|